Match tier Likely match
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-05

Xiaolei Shi

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Specialist for Translational Research

Also affiliated: Shenyang Pharmaceutical University (2008); Jiangsu University (2017); Nanjing Agricultural University (2025–2026); General Electric (United States) (2004–2006); University of Wisconsin–Madison (2025); North Carolina State University (2012–2017); Iowa State University (2019–2023); Jilin University (2015); Chinese Academy of Sciences (2020–2021); China University of Petroleum, Beijing (2020–2026); Dalian University of Technology (2009–2010); Shenyang Institute of Computing Technology (China) (2021); Yidu Central Hospital of Weifang (2018); CRRC (China) (2024); GE Global Research (United States) (2004–2006); Institute of High Energy Physics (2020); Jiangsu Hengrui Medicine (China) (2021); Huashan Hospital (1997); China University of Petroleum, East China (2019–2025); University of Chinese Academy of Sciences (2020–2021); Louisiana Tech University (2007); Stanford University (2003)

19 h-index 60 pubs 1,202 cited

  • Animals
  • Humans
  • Male
  • Methylcellulose
  • Chromatography, High Pressure Liquid
  • Rats
  • Arachis
  • Tablets
  • Printing, Three-Dimensional
  • Delayed-Action Preparations
  • Solubility
  • Theophylline
  • Drug Carriers
  • Particle Size
  • Administration, Cutaneous

Biography and Research Information

OverviewAI-generated summary

Xiaolei Shi's research focuses on the development and fabrication of drug delivery systems. Shi has investigated the use of 3D printing technology to create extended-release tablets, including those utilizing hydroxypropyl methylcellulose (HPMC) hydrogels for theophylline delivery. Other work involves integrated manufacturing strategies for delivery systems, such as combining 3D printing and freeze-drying with gelatin/alginate hybrid hydrogels. Shi has also explored creating shelf-stable, gel-based delivery systems for probiotics through similar methods. Additionally, research has included the development of hyaluronic acid-based mesoporous silica nanoparticles for delivering therapeutic agents for oral cancers and employing high-pressure liquid chromatography for pharmacokinetic studies. Shi's work also extends to food science, examining plant-based bigels as alternatives in baked goods.

Metrics

  • h-index: 19
  • Publications: 60
  • Citations: 1,202

Positions

  • Specialist for Translational Research 2022–present
    University of Wisconsin–Madison Technology Entrepreneurship Office (TEO) ORCID
  • Specialist for Translational Research publications 2026
    University of Arkansas at Fayetteville ORCID
  • Adjunct Assistant Professor 2017–2022
    Iowa State University Food Science and Human Nutrition ORCID

Selected Publications

  • Phenotypic characterization and germplasm screening for sprout agronomic performance in Huang-Huai soybean accessions (2026)
    Industrial Crops and Products DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

13 Collaborators 4 Institutions 3 Countries

Top Collaborators

Similar Researchers

Based on overlapping research topics